Clinical Trial Update: Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR) [Phase 3]

View source ↗

Summary

This Phase 3 trial (FAST-MDR) in France assesses the feasibility of a new six-month treatment for multidrug-resistant tuberculosis; the study is not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis
• Tuberculosis

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: MDR-TB, Tuberculosis Multi Drug Resistant Active | Phase 3 | Status: NOT_YET_RECRUITING